Jefferies Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-566
Closed -$382K 1505
2021
Q4
$382K Buy
566
+14
+3% +$8.52K ﹤0.01% 1246
2021
Q3
$361K Buy
552
+441
+397% +$377K ﹤0.01% 1334
2021
Q2
$112K Buy
+111
New +$97.2K ﹤0.01% 1482

Other funds holding AGL

Jefferies Group's AGL Position: Q1 2022 in Review

Jefferies Group sold out of Agilon Health (AGL) in Q1 2022, closing a stake of 566 shares — an estimated $382K sold.

Jefferies Group first reported a position in AGL in Q2 2021 and held it in 3 quarters. The position peaked at $382K in Q4 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.

  • Jefferies Group reported no remaining Agilon Health position as of Q1 2022 after selling out during the quarter.
  • Jefferies Group sold 566 Agilon Health shares in Q1 2022, an estimated $382K.
  • Jefferies Group first reported a position in Agilon Health in Q2 2021 and held it in 3 quarters.
  • Jefferies Group's Agilon Health position peaked at $382K in Q4 2021.
  • 121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.